Ovbiagele Bruce
Stroke Center, Department of Neurology, University of California, Los Angeles Medical Center, Los Angeles, CA 90095, USA.
Acad Emerg Med. 2006 Feb;13(2):215-22. doi: 10.1197/j.aem.2005.07.035. Epub 2006 Jan 25.
Stroke and transient ischemic attack (TIA) are increasingly common conditions that are associated with significant morbidity and mortality. The strongest predictor of recurrent stroke risk is an initial stroke or TIA; in fact, nearly 30% of all strokes are recurrent events. It is often the emergency department (ED) physician who, while treating the initial event, has the first opportunity to initiate effective preventive strategies, including pharmacotherapy and behavior modification. Evidence- and consensus-based guidelines are well established for the use of antiplatelet medications, anticoagulants, and antihypertensives for prevention of secondary stroke. Recent evidence suggests that the use of statins may be associated with improved clinical outcomes after ischemic stroke. In addition, behavioral interventions, such as smoking cessation, exercise, diet, and stroke education, can help patients avoid stroke recurrence. By initiating prevention therapies during the acute stroke or TIA encounter, EPs convey the message to patients that these therapies are important for the prevention of recurrent events and are an essential part of the treatment.
中风和短暂性脑缺血发作(TIA)是越来越常见的疾病,与显著的发病率和死亡率相关。复发性中风风险的最强预测因素是首次中风或TIA;事实上,所有中风中有近30%是复发性事件。通常是急诊科(ED)医生在治疗首次发作时,有第一个机会启动有效的预防策略,包括药物治疗和行为改变。基于证据和共识的指南已完善确立,用于使用抗血小板药物、抗凝剂和抗高血压药物预防继发性中风。最近的证据表明,使用他汀类药物可能与缺血性中风后改善临床结局有关。此外,行为干预,如戒烟、运动、饮食和中风教育,可以帮助患者避免中风复发。通过在急性中风或TIA发作期间启动预防治疗,急诊医生向患者传达这些治疗对预防复发性事件很重要且是治疗的重要组成部分的信息。